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The cholesterol transfer function of steroidogenic acute regulatory protein (StAR) is 
uniquely integrated into adrenal cells, with mRNA translation and protein kinase A (PKA) 
phosphorylation occurring at the mitochondrial outer membrane (OMM). The StAR 
C-terminal cholesterol-binding domain (CBD) initiates mitochondrial intermembrane 
contacts to rapidly direct cholesterol to Cyp11a1 in the inner membrane (IMM). The con-
served StAR N-terminal regulatory domain (NTD) includes a leader sequence targeting 
the CBD to OMM complexes that initiate cholesterol transfer. Here, we show how the NTD 
functions to enhance CBD activity delivers more efficiently from StAR mRNA in adrenal 
cells, and then how two factors hormonally restrain this process. NTD processing at 
two conserved sequence sites is selectively affected by StAR PKA phosphorylation. The 
CBD functions as a receptor to stimulate the OMM/IMM contacts that mediate transfer. 
The NTD controls the transit time that integrates extramitochondrial StAR effects on 
cholesterol homeostasis with other mitochondrial functions, including ATP generation, 
inter-organelle fusion, and the major permeability transition pore in partnership with other 
OMM proteins. PKA also rapidly induces two additional StAR modulators: salt-inducible 
kinase 1 (SIK1) and Znf36l1/Tis11b. Induced SIK1 attenuates the activity of CRTC2, 
a key mediator of StAR transcription and splicing, but only as cAMP levels decline. 
TIS11b inhibits translation and directs the endonuclease-mediated removal of the 3.5-kb 
StAR mRNA. Removal of either of these functions individually enhances cAMP-mediated 
induction of StAR. High-resolution fluorescence in situ hybridization (HR-FISH) of StAR 
RNA reveals asymmetric transcription at the gene locus and slow RNA splicing that 
delays mRNA formation, potentially to synchronize with cholesterol import. Adrenal cells 
may retain slow transcription to integrate with intermembrane NTD activation. HR-FISH 
resolves individual 3.5-kb StAR mRNA molecules via dual hybridization at the 3′- and 
Abbreviations: 3′EU, oligomer set targeting extended 3′UTR; AMG, aminoglutethimide; CBD, cholesterol-binding domain; 
CTD, C-terminal domain; CHX, cycloheximide; FISH, fluorescence in situ hybridization; HR-FISH, high-resolution fluores-
cence in situ hybridization; IMM, inner mitochondrial membrane; N-SIM, Nikon’s structured illumination microscope; NTD, 
N-terminal domain; OMM, outer mitochondrial membrane; PKA, protein kinase A; p-RNA, primary RNA; sp-RNA, spliced 
primary RNA; SIK1, salt-inducible kinase 1; StAR, steroidogenic acute regulatory protein.
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inTrODUcTiOn
Steroidogenic acute regulatory protein (StAR) functions as a key 
determinant of steroidogenesis by transferring cholesterol from 
the outer mitochondrial membrane (OMM) to Cyp11a1 in the 
inner mitochondrial membrane (IMM) (1–4). Cyp11a1 metabo-
lizes this cholesterol in the adrenal mitochondria very rapidly 
such that accumulation only occurs when constraints are placed 
on this turnover. The Cyp11a1 inhibitor aminoglutethimide 
(AMG) causes the accumulation of 3–5 cholesterol molecules per 
Cyp11a1 and increased cholesterol–Cyp11a1 complex formation 
(5). Turnover is driven by NADPH generated from the Krebs 
cycle (isocitrate dehydrogenase), but highest potency is achieved 
with succinate dehydrogenase linked to the ATP-dependent 
NADH/NADPH transhydrogenase (NNT) (6). CYP11a1 not 
only depends on the shuttling of ferredoxin between the flavopro-
tein reductase and CYP11a1 (7) but also competes with electron 
transfer to IMM Cyp11b1 (8).
The role of StAR has been definitively established through 
transgenic deletion of its gene in mice, which reproduces the 
pathology of human adrenal lipidemic hyperplasia (ALH) (9, 10). 
This role extends to testis Leydig cells and multiple cell types in 
the ovary. Mutations that cause the human disease are concen-
trated in the cholesterol-binding domain (CBD) rather than the 
N-terminal domain (NTD) (11). One mutation (R182) resolves 
cholesterol exchange activity to optimal levels when steroidogenic 
activity is deficient (12, 13). The NTD retains the net positive 
charge common to mitochondrial import sequences, but with 
appreciable helical content and dual cleavage sites that are atypi-
cal for mitochondrial target sequences. NTD modulatory activity 
is suggested by the involvement of the 30–62 sequences in the 
binding of StAR to VDAC2, which then facilitates both choles-
terol transfer and NTD cleavage (14). Deletion of the NTD (N-47 
mouse), while clearly establishing cholesterol transfer activity for 
the CBD alone, equally establishes a major modulatory role for 
the NTD that is tissue-dependent (15). StAR functions without 
the NTD to mediate linkage to lipid droplets (16, 17), including in 
a reconstituted system employing rat adrenal mitochondria (18).
Steroidogenic acute regulatory protein activity under hormo-
nal control is mediated by phosphorylation at S-194 in the CBD, 
by cAMP and protein kinase A (PKA) in fasciculate cells, and by 
Ca-dependent kinases in glomerulosa cells (19, 20). StAR activity 
is inhibited by cholesterol sulfate such that cholesterol sulfatase can 
enhance activity (21). The large number of cholesterol molecules 
transferred per each molecule of transiting StAR implicates the 
controlled generation of OMM/IMM contacts by receptor-like 
activity derived from the CBD (1). StAR, or STARD1, was 
the first member of a family that was identified based on the 
CBD sequence and structure. Forms D1 and D3 differ in their 
N-terminal targeting to mitochondria and to late endosomes, 
respectively; D4, D5, and D6 differ in their carrier specificity for 
cholesterol derivatives (22). The phosphatidylcholine exchange 
protein (STARD2) also functions at the mitochondria but with 
a partnering enzyme, Acot13 (23). Cholesterol transfer into the 
adrenal cortex mitochondria in  vivo depends on continuous 
translation of the 37-kDa StAR pre-protein with concomitant 
phosphorylation by PKA. Inhibition with cycloheximide (CHX) 
halts adrenocorticotropic hormone (ACTH)-stimulated steroi-
dogenesis within 5  min, while accumulating cholesterol in the 
OMM remains inaccessible to IMM Cyp11a1 (24–26). This 
intermembrane cholesterol barrier in the adrenal mitochondria 
caused by CHX treatment is readily breached by mild mitochon-
drial disruption, including the elevation of Ca2+. Such artificial 
transfer also removes succinate-initiated NNT support for this 
CHX-sensitive Cyp11a1 activity (6).
The NTD and the timing of the conserved IMM processing 
link StAR activity to other processes. PBR/TSPO associates 
with abundant VDAC1 to control OMM/IMM contacts at 
cholesterol-rich regions (27), including through the formation of 
a transmembrane complex (28). Participation of the mitochon-
drial permeability transition pore (MPFP) is a common feature 
of these processes. PAP7/ACBD3, which partners with TSPO, is a 
suppressor of SREBP forms, thus representing a link to cholesterol 
and fatty acid homeostasis (29). GTP enhances the in vitro mito-
chondrial uptake of cholesterol via GTPase activity in partnership 
with Ca (30). GTPases, such as Mfn2 and Opa1, which mediate 
the continuous dynamics of inter-mitochondrial fusion and fis-
sion, play pivotal roles in cAMP-stimulated cholesterol transfer 
(31). Mitochondrial fusion with the ER through sigma receptor 
sites has also been implicated (14). MAPK phosphorylation of 
StAR (S-232) stimulates StAR activity while slowing N-terminal 
cleavage (32).
In addition to NTD intervention, StAR activity is restricted 
at the mRNA level by the salt-inducible kinase (SIK1) (33) and 
the RNA-binding protein Znf36l1/Tis11b (34) which are each 
rapidly induced by cAMP. A critical feature of StAR mRNA is its 
alternative polyadenylation (1.6- and 3.5-kb StAR mRNA), which 
introduces an extra 2 kb of 3′UTR, facilitating additional regula-
tion of mRNA stability and translation (34). Here, we have used 
the high-resolution fluorescence in  situ hybridization method 
(HR-FISH) (35, 36) to image primary (p-RNA) and spliced StAR 
transcripts (sp-RNA) at the StAR gene loci in Y-1 and MA-10 
5′-ends and reveals an unexpectedly high frequency of 1:1 pairing with mitochondria 
marked by the matrix StAR protein. This pairing may be central to translation-coupled 
cholesterol transfer. Altogether, our results show that adrenal cells exhibit high-efficiency 
StAR activity that needs to integrate rapid cholesterol transfer with homeostasis and pul-
satile hormonal stimulation. StAR NBD, the extended 3.5-kb mRNA, SIK1, and Tis11b 
play important roles.
Keywords: star, sik1, Tis11b, fluorescence in situ hybridization, Pcr
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cells (37, 38). Y-1 adrenal cells are distinguished by a proportion 
of basally active loci that produce cytoplasmic mRNA sufficient 
to mediate peak activation of steroidogenesis by PKA. Activation 
of individual cells by Br-cAMP increases StAR transcripts at the 
gene loci, where we have resolved primary and spliced transcripts 
before observing increased mRNA in the cytoplasm and specific 
positioning at the mitochondria.
The need for continuous translation places particular demands 
on the hormonal stimulation of transcription. StAR transcrip-
tion depends on multiple promoter sites within 300  bp of the 
transcription start site, including SF1, CREB, GATA4, and AP1, 
which are further supplemented by newly synthesized C/EBP 
and NF4a1/Nurr77 (39, 40). CREB activity, which is essential, 
is activated by PKA-mediated phosphorylation at S133, which 
mediates synergistic recruitment of the histone acetyl transferase 
CBP and the coactivators of the CRTC/TORC family (38, 41–43). 
PKA deactivates the repressor kinases SIK1 and SIK2, which 
otherwise maintain CRTC2 in an inactive phosphorylated state. 
Merely inhibiting SIK is sufficient to stimulate the expression of 
StAR and most steroidogenic genes in Y-1 cells (33, 41). SIK1 is 
rapidly induced in adrenal cells in vivo and in cultured Y-I cells 
by PKA at an early stage of increased StAR expression (41, 42). 
Importantly, PKA also inhibits activity through S577 phospho-
rylation, and thus, this increase does not impact StAR until PKA 
activity declines (38). Br-cAMP also rapidly stimulates Znf36l1/
Tis11b, which binds to specific dual AU-rich elements in the 
extended 3′UTR. This homodimer complex recruits ribonucle-
ases to selectively degrade the 3.5-kb StAR mRNA. Here, we show 
that removal of TIS11b enhances the potency of Br-cAMP as a 
stimulant of StAR expression. Another cAMP-sensitive protein, 
Akap1, may work with TIS11b to position StAR mRNA at the 
mitochondria via elements in the extended 3′UTR (44).
The work presented here provides evidence that mRNA gen-
eration, mitochondrial positioning, translation, and N-terminal 
targeting of new StAR proteins may be coordinated to match 
organizational steps involving cholesterol transfer across the 
mitochondrial membranes, consistent with an integrated CHX-
sensitive mechanism.
MaTerials anD MeThODs
cell culture and Dna Vector Transfection
The MA-10 mouse Leydig tumor cell line (a gift of Dr. Mario 
Ascoli) was derived from the Leydig tumor M5480P (45). Y-1 
mouse adrenocortical tumor cells were expanded from a subclone 
obtained from Dr. Bernard Schimmer (University of Toronto) 
with a lower passage number than those available from ATCC. 
Cells were grown according to previously described method (34). 
DNA vectors were transfected using TransIt-LT1 (Mirus Bio) and 
Lipofectamine 2000 (Invitrogen) according to the manufacturers’ 
protocols.
sirna Transfection and shrna 
cell line generation
ON-TARGETplus SMARTpool siRNA sequences against mouse 
TIS11b, along with non-target siRNA sequences, were purchased 
from Dharmacon, Inc. (Lafayette, CO, USA). They were tran-
siently transfected into MA-10 cells using the DharmaFECT 
1 reagent according to the manufacturer’s protocol. siRNA-
transfected samples were prepared according to a previously 
described method (34). The GeneClip™ U1 Hairpin Cloning 
system was used to express short hairpin RNAs (shRNAs) in 
MA-10 and Y-1 cells. Stable cell lines were generated using a 
positive selection marker, neomycin. The U1 promoter was 
previously employed with success to knock down the target 
genes in these cell lines.
Western Blot analysis
Protein samples were prepared and assayed according to a previ-
ously described method (34). Protein bands were visualized using 
ECL reagent and Hyperfilm (Amersham Biosciences, Arlington 
Heights, IL, USA).
real-time rT-Pcr
Primer design and cDNA synthesis were performed according 
to previously described methods (34, 37). q-PCR was performed 
using a BioRad CFX96TM Real-Time PCR Detection System. 
The q-PCR protocol was carried out as follows: initial denatura-
tion at 95°C for 3 min, followed by 40 cycles of 10 s at 95°C, 30 s 
at 55°C, and 10 s at 95°C. Fluorescence signals were recorded at 
each extension step at 55°C. A melting curve analysis was then 
performed from 65 to 95°C at increments of 0.5°C for 5 s to assess 
amplicon specificity.
northern Blot analysis
Total RNA was isolated using a QIAGEN RNeasy Mini kit per 
the manufacturer’s instructions. Approximately 10  μg of total 
RNA was resolved by electrophoresis in a 1% (weight/volume) 
agarose–formaldehyde–formamide denaturing gel and trans-
ferred to a Hybond-N+ membrane (Amersham Biosciences) 
for approximately 16  h via the capillary method. RNA on the 
membrane was immobilized with a UV Stratalinker 1800 in 
auto mode (1900  J ×  100 for 30  s). The membrane was then 
prehybridized at 65°C for 1 h in QuickHyb hybridization solu-
tion (Stratagene). Hybridization was performed at 65°C for 2 h 
in QuickHyb with a 0.9-kb mouse StAR cDNA probe that was 
radiolabeled with [α-32P]dCTP (PerkinElmer, Norwalk, CT, 
USA; 3000  Ci/mmol) using a Ready-To-Go DNA-labeling kit 
(Amersham Biosciences). The membrane was exposed overnight 
and scanned using a phosphorimager (Molecular Dynamics, 
Sunnyvale, CA, USA) (34).
high-resolution Fluorescence In Situ 
hybridization
The term HR-FISH has been employed to distinguish the use of 
a probe set consisting of 40 fluorescent 20mers. The RNA probe 
sets for StAR were generated using the Stellaris probe designer 
(http://www.biosearchtech.com/stellarisdesigner/). Samples were 
prepared according to a previously described method (37). 
Freshly prepared p-RNA (Quasar-570, Biosearch Technology), 
sp-RNA (Quasar-570, Biosearch Technology), and 3″ EU 
(Quasar-570, Biosearch Technology) probe sets and antibodies 
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for StAR and TIS11B were used. Clean coverslips were placed 
over the samples to prevent the hybridization solution [10% 
dextran sulfate (Sigma), 10% deionized formamide (Ambion), 2× 
SSC] from drying during the incubation. Samples were incubated 
in a dark humidified chamber at 37°C overnight. After a 30-min 
wash in wash buffer, samples were incubated in DAPI nuclear 
stain (wash buffer with 5 ng/ml DAPI) to counterstain the nuclei 
for 30 min. For combined FISH, an extra wash step was needed 
for the secondary antibody. Samples were processed according to 
a previously described method (37).
Image Acquisition and Analysis
To detect and visualize p-RNA, sp-RNA, and mRNA, we used 
an Olympus wide-field fluorescence microscope (Model IX81) 
and the Nikon’s structured illumination microscope (N-SIM) to 
obtain higher resolution images.
Olympus IX81
Images were captured by Olympus IX81 motorized inverted 
microscope equipped with a Hamamatsu Orca2 camera. Images 
were obtained with 0.2 μm spacing with the 100× oil objective 
and projected onto a single plane or 3D image. At least 30 
Z-sections at 0.2 μm intervals were taken to cover the entire 
thickness of the cell. The exposure times ranged from 0.2  s 
(nuclear loci) to 4  s (cytoplasmic mRNA). The exposure time 
increases not only sensitivity approximately proportionately 
but also the background. Comparisons are made at the same 
exposure times. The target size is much smaller than the image 
due to the dispersion of the fluorescent light from the target. 
Loci have multiple clustered RNA molecules either p-RNA or 
sp-RNA. These terms have been used rather than pre-mRNA 
and mRNA to emphasize the absence of information on RNA 
processing. We term this fluorescent cluster the RNA locus, 
which elsewhere has been shown to overlap with the gene 
(DNA) locus. p-RNA and sp-RNA at the RNA are separate in 
the images. Captured images were deconvoluted with Slidebook 
5.0 software (Intelligent Imaging Innovations, Inc.) for further 
analysis.
Nikon’s Structured Illumination Microscope
Super-resolution imaging was performed with an N-SIM 
micro scope system (Nikon) equipped with a SR Apo TIRF 
100× 1.49  N.A. oil immersion objective and an iXon3 camera 
(Andor Technology). 3D-SIM image stacks were acquired with 
a Z-distance of 0.2 μm, covering the entire thickness of the cell 
(about 6 μm) using laser power setting 40%. The camera settings 
were configured as follows: format for capture, no binning; expo-
sure time, 50–200 ms (one frame recommended); readout mode, 
EM gain 10 MHz 14-bit; gain multiplier, 20–200 ms (max 300); 
conversion gain. 5.1× 15 raw images per plane were acquired and 
computationally reconstructed using the reconstruction slice 
system from NIS-Elements software (Nikon).
Data analysis
Statistical significance was determined using Student’s t-test 
or ANOVA; P  <  0.05 was considered statistically significant; 
*P < 0.05, **P < 0.01, and ***P < 0.001. Data were analyzed using 
PRISM software (San Diego, CA, USA).
resUlTs
n-Terminal Modulation of star in Mouse 
cell lines
Steroidogenic acute regulatory protein activity is depend-
ent on co-translational phosphorylation prior to N-terminal 
processing. This process leads to the inhibition of cholesterol 
metabolism within 5 min in primary rat adrenal cells or in vivo 
(1). In MA-10 cells, StAR is barely detectable until cells undergo 
60 min of stimulation by Br-cAMP. To test whether PKA phos-
phorylation at S-194 affects this processing, we substantially 
elevated StAR protein levels via the transfection of StAR dUTR 
prior to the addition of Br-cAMP (Figure 1A). After 30 min of 
stimulation, extensive new active phosphorylation of p37 was 
evident, although less than half of this p37 was processed to 
p30, and scarcely any of the third products, p32, was detectable. 
In the absence of vector-derived StAR, appreciable amounts of 
p37, p32, and p30 were generated after 60 min of stimulation by 
Br-cAMP in proportions similar to those seen with the vector. 
Again, phosphorylation was appreciable for p30 but was scarcely 
detectable for p32.
Evidently, transfected StAR is phosphorylated and cleaved 
at the mitochondria at very similar rates to those observed for 
endogenous StAR. Mature p30 and, in particular, p32 are phos-
phorylated at much lower levels, indicating that the PKA targeting 
of S-194 impacts these cleavage reactions. Phosphorylation occurs 
outside the mitochondria and therefore before predominant 
cleavage by the IMM proteases. Either S-194 phosphorylation 
enhances removal of the processed forms in the matrix or slows 
their formation.
This N-terminal processing is very consistent across species 
and adrenal cell lines. The commonly used COS-1 transfection 
model (monkey kidney line), however, demonstrates a substan-
tial deficiency in the rate of cleavage compared to Y-1 and MA-10 
cells (Figure 1B).
n-Terminal Modulation of star 
in Primary Bovine adrenal cells
Bovine adrenal cortex tissue is the best source of information 
regarding human adrenal mechanisms. The electron transfer 
activity of purified Cyp11a1 and its partnering ferredoxin was 
established in bovine adrenal tissue (7). Cultured primary bovine 
adrenal cortex (BAC) cells, which predominantly express cortisol, 
are stimulated fourfold by ACTH (47). Inhibition of protein 
synthesis by CHX has no effect on mitochondrial cholesterol 
accumulation but prevents increases in both cholesterol–Cyp11a1 
complex formation and metabolism (Figure 2A).
N-terminal domain sequences are highly conserved across 
species (Figure 2B), including the two major cleavage products. 
These have been characterized by mass spectrometry for bovine 
StAR and found to have masses of 27,503 and 25,906 Da (48). The 
major cleavage products in BAC cells match those observed in 
MA-10 cells and with vector expression in COS-1 cells.
FigUre 1 | characterization of n-terminal sequence changes in the 3′UTr of mouse star mrna. (a) Design for the transfection of MA-10 cells with 
dUTR–StAR and stimulation by Br-cAMP (a). Diagram showing empty vector and StAR expression vector (StAR dUTR) (b). Comparison of the N-terminal cleavage 
and phosphorylation of natively expressed and transfected StAR dUTR. Each is stimulated for 0, 30, and 60 min (c). (B) Diagram showing empty vector and StAR 
expression vectors with different 3′UTRs (a). Effects of StAR 3′UTR on basal expression in StAR cDNA constructs. Western blot of StAR protein in MA-10, Y-1, and 
COS-1 cells transfected with these vectors (b) (46).
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Single and combinatorial mutation of the A (M30) and B 
(M28) sites in the bovine sequence reveals a complex additive 
cleavage process; however, mutation in COS-1 cells did not 
affect StAR activity (without PKA activation). Removal of site 
A prevents the formation of p30 but results in a concomitant 
increase in p35, indicating that this cleavage form is an inter-
mediate during the generation of p30 (Figure 2C). Mutation of 
site B decreases p30 and removes p28 while revealing a major 
product with a mobility that is intermediate between p28 and 
p30 (p29). Mutation of B exerts no effect on p35. We envisage 
p29 as the major precursor to p28. Dual mutation confirms an 
additive response, further establishing the independence of the 
two pathways.
In primary BAC cells, p37 pro-StAR is cleaved into two 
products with different sizes, lower (28  kDa) and higher 
(30 kDa), each of which can be divided into four further spe-
cies in 2D gels based on pI (20). In culture, PKA activation in 
either glomerulosa or fasciculate BAC appreciably increases 
the total amount of newly cleaved products within minutes. 
The low-pI p28 and p30 phosphorylated forms are increased 
by 5- to 10-fold (Figure  2D). In glomerular cells, the same 
pattern is observed after stimulation with angiotensin and K+, 
which both increase intracellular Ca and calmodulin kinase 
levels. Aldosterone synthesis responds proportionately (dibutyl 
cA > angiotensin > K+) (20). The close correlation between the 
appearance of N-terminal cleavage and PKA phosphorylation 
suggests that these intermediate NTD products contribute to 
cholesterol transfer. The dual p28 and p30 products resolved by 
pI indicate further posttranslational modification in addition to 
phosphorylation at S-194. S-232 phosphorylation delivered by 
MAPK represents one possibility (32).
Y-1 cells exhibit higher Basal star 
expression and an acute response 
That is limited to 15 min
Y-1 adrenal cells, like their primary counterparts and in contrast to 
MA-10 cells, possess sufficient basal mRNA to mediate maximum 
steroidogenesis within 15 min without a corresponding increase 
in mRNA. This basal expression has been observed utilizing a 
combination of q-PCR and HR-FISH microscopy, described in 
detail elsewhere (37). The locations for q-PCR target probes in 
the StAR primary transcript (p-RNA) and spliced transcripts 
(sp-RNA/mRNA) are shown in Figure 3A. Figure 3B indicates 
the presence of both p-RNA and sp-RNA/mRNA at a ratio of 
1:4 under basal conditions. In both cell types, the ratio of q-PCR 
at early (E7-S) and late (E7-L) sites in the 3′UTR is close to 1:1, 
indicating complete transcription of the 3′UTR and formation 
of the 3.5-kb form at a far great frequency than the 1.6-kb form 
(Figure 3C). The much higher p-RNA levels in Y-1 cells compared 
to MA-10 cells indicate active synthesis under basal conditions. 
Stimulation by Br-cAMP reveals a fourfold rise in both the early 
and late introns (1 and 6), but no increase in either exon 7 or 
spliced transcripts consistent with the approximately 30-min 
delay in elongation and splicing reported previously for Y-1 and 
MA-10 cells (37, 38).
We examined changes at the nuclear loci using HR-FISH. 
The HR-FISH probe locations on the StAR primary transcript 
FigUre 2 | nTD cleavage in cOs-1 cells parallels changes in primary bovine adrenal cells. (a) Effects of aminoglutethimide (0.5 mM) and cycloheximide 
(0.2 mM) on cholesterol transfer in ACTH-stimulated cultured bovine adrenal cells (47) are shown in (a) mitochondrial cholesterol and (b) determination of 
cholesterol–CYP11A1 complex. Data are represented as mean ± SEM, ***P < 0.001. (B) Multispecies sequence comparison of StAR NTD that shares conserved 
MMP cleavage sites A and B. The typically used mouse and bovine identification of products is compared to the average M.W determined by mass spectrometry for 
bovine products. (c) Mutation of conserved cleavage sites (M28, M30) in the NTD of bovine StAR. The blue lines indicate the predicted cleavage sites for the 
production of the 30- and 28-kDa form of StAR. Expression of CMV bovine StAR vectors in COS-1 cells. Effects of mutations as observed by immunoblotting for 
StAR (48). (D) 2D gel determinations of NTD cleavage products in BAC cells (20). Decreases (p28, #1–2) and increases (p28, #3–4; p30, #5–6) of NTD cleavage 
products are shown in response to dibutryl cAMP. Data are represented as mean ± SEM, ***P < 0.001.
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(p-RNA) and spliced form are shown in Figure  3D. The dual 
presence of p-RNA and sp-RNA at the two StAR loci in Y-1 cells 
after 60-min stimulation with Br-cAMP is shown in Figure 3E. 
Elsewhere, we have shown that spliced and unspliced transcripts 
can be resolved at these loci with N-SIM ultrahigh-resolution 
microscopy. Separation in MA-10 cells varies from 100 to 300 nm 
(38). Figure  3F shows that p-RNA and sp-RNA are detectable 
at low levels in association with the loci in most adrenal cells, 
although they are undetectable in MA-10 cells. Cytoplasmic 
mRNA is also appreciable, corresponding to higher levels than 
those observed in MA-10 cells, even after 60 min of stimulation. 
There are significant increases for both p-RNA and sp-RNA in 
approximately half of the loci after 15 min, but no increases in 
cytoplasmic mRNA.
High-resolution fluorescence in situ hybridization confirms 
the q-PCR basal expression of StAR. Thus, in contrast to 
MA-10 testis cells, HR-FISH imaging of Y-1 cells reveals p-RNA 
and sp-RNA at the loci, although at much lower levels than 
those observed after 60  min of stimulation. Variable levels of 
expression can be seen at the loci in each cell, representing 
different numbers of transcripts. Some cells have only one 
active locus, and some have no active loci, corresponding to 
the asymmetric activation of StAR loci and the asynchronous 
responses of individual cells as previously reported for MA-10 
cells (37, 38). Importantly, mRNA is visible in the cytoplasm 
under basal conditions with this greater experimental sensitivity. 
Following a 15-min stimulation by Br-cAMP that induces maxi-
mum steroidogenesis in Y-1 cells (1), the intensity of p-RNA 
expression at the loci increases. However, the increase in sp-
RNA is modest, consistent with the q-PCR results (Figure 3B), 
indicating no increase in cytoplasmic mRNA, despite maximal 
steroidogenesis.
Y-1 cells share Undergo early Onset 
slow splicing and Delayed rapid 
splicing Phases
q-PCR analyses of Br-cAMP stimulation through 120  min 
(Figure 4A) indicate that both early and extended sites on the 
3′UTR only increase after 30  min, although with comparable 
FigUre 3 | Pcr determination of acute activation of star transcription in Y-1 adrenal cells. (a) Design of PCR primers for StAR p-RNA and sp-RNA/
mRNA. (B) PCR time course for Y-1 cells [p-RNA (E1/I1) versus sp-RNA (E5/E6)] (0–30 min every 3 min). (c) PCR time course for E7-S and E7-L (0–15 min). 
(D) HR-FISH 20-mer fluorescent probes for StAR p-RNA and sp-RNA/mRNA. (e) Co-expression of p-RNA and sp-RNA at StAR loci in Y-1 cells after 60 min of 
stimulation. (F) Locus changes and cytoplasmic mRNA in Y-1 cells under basal conditions and after acute activation for 15 min (p-RNA versus sp-RNA) (sensitivity is 
high for mRNA detection).
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copy numbers for the E5 and E6 spliced RNA. In Figure 4B, the 
images of StAR loci in multiple cells reveal that as stimulation 
progresses, more loci per cell become active for both p-RNA 
and sp-RNA, again mirroring the q-PCR results. The intensities 
of p-RNA and sp-RNA at the loci also increase as stimulation 
progresses. In Figure 4C, the images of typical nuclei indicate that 
levels of p-RNA and sp-RNA are not comparable until 60 min of 
stimulation. This is consistent with the delay in splicing identified 
from the q-PCR analyses.
Figure  4D diagrams different optical slices taken at various 
cellular depths. The StAR loci are always positioned close to 
the nuclear midline, whereas the cytoplasmic mRNA is largely 
distributed at lower levels. To determine the proportions and 
distribution of the 1.6- and 3.5-kb StAR mRNA forms, we used 
both sp-RNA probes and an additional set, targeting an 800-bp 
sequence at the 3′ end of the 3.5-kb mRNA UTR (3′EU probes). 
Figure 4E indicates that cytoplasmic 3.5-kb mRNA exhibits dual 
labeling. These probes extensively overlap at the loci, which appear 
strongly yellow. Figure 4F shows the measurement of the nucleus, 
locus, and individual messages. The length of the diameter of Y-1 
cell is approximately 5–10 μm. The length of a diffraction-limited 
mRNA dot is about 0.2 μm. The juxtaposition of the two probes 
on the 3.5-kb mRNA is evident for approximately 60% of mRNA 
particles (Figure 4G). The size distribution is consistent with a 
single mRNA species (37). However, equal numbers of mRNAs 
are singly hybridized either by sp-RNA or 3′EU. Single 3′EU 
hybridization should represent incomplete binding to the 3.5-kb 
mRNA, similar to single sp-RNA hybridization. Detection of 
the 1.6-kb mRNA form is evidenced by the enrichment of such 
binding in lower Z-slices.
The mitochondria uniformly express the StAR protein in 
the inner matrix (38). Interestingly, after 60 min of stimulation, 
approximately half of StAR sp-RNA hybridization, which is 
predominantly represented by the 3.5-kb mRNA form, pairs with 
StAR proteins (Figure 4H). StAR mRNA is expected to position 
on polyribosomes attached to the OMM (Figure  4I). Adrenal 
mitochondria have a diameter of approximately 0.5 μm (15).
siK1 is induced rapidly via 
expression of the 4.4-kb mrna but 
Prior to the increase in Protein levels
CRTC2 activation, which is essential for StAR transcription, 
is suppressed by SIK1 and SIK2 in adrenal cells. Each shares a 
conserved mechanism of control, but SIK2 is predominantly 
constitutive and located in the cytoplasm, whereas SIK1 in 
highly inducible by PKA. SIK1 is regulated through dual 
phosphorylation at T182 by LKB1 in the catalytic domain and 
by PKA at SIK577 in the C-terminal region (43) (Figure 5A). 
After Br-cAMP stimulation, SIK1 p-RNA increases to a steady 
FigUre 4 | spatiotemporal regulation of star mrna in Y-1 cells. (a) Time course of 0–120 min for the stimulation of StAR RNA as determined by q-PCR to 
detect the 3′UTR (E7-S, E7-L) and translated sequence (E5/E6). (B) p-RNA and sp-RNA at StAR loci in multiple cells; sensitivity is sufficient to detect RNA 
concentrated at loci but not cytoplasmic mRNA. Lower expression of mRNA requires a higher sensitivity setting for the microscope. (c) Loci in representative nuclei 
(0–180 min). p-RNA, sp-RNA, and merged. (D) Nuclear positioning for Z-sections a, b, and c. The positioning of sp-RNA versus 3′EU HR-FISH probes. StAR loci are 
found near the nuclear midline; cytoplasmic StAR mRNA is primarily observed between slice b and the adherent plasma membrane (37). (e) Z-projections of HR-FISH 
for StAR RNA at high sensitivity (N-SIM microscope) after stimulation for 60 and 120 min (dual addition of 3′EU and sp-RNA). StAR loci (yellow, due to probe overlap), 
sp-RNA (red), and 3′EU (green) visualize cytoplasmic mRNA. DAPI (blue) visualizes nuclear DNA. (F) Measurements of the nucleus, locus, and individual message. 
Scale bar, 1 μm. (g) N-SIM mRNA images after 120 min in the lower portion of the cell (slice c) with dual labeling by sp-RNA and 3′EU. Enlargement resolution of dual 
labeling with StAR mRNA and sp-RNA or 3′EU. (h) HR-FISH of StAR mRNA (sp-RNA) and immunochemistry of StAR proteins after 60 and 180 min of stimulation 
employing N-SIM microscopy. The StAR protein is present in the matrix of all Y-1 mitochondria (38). (i) Enlarged region after 60 min of stimulation showing the pairing 
of StAR mRNA and mitochondrial matrix-localized StAR proteins. Diagram of the spatial relationship between matrix proteins and OMM-associated StAR mRNA.
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FigUre 5 | induction and mobilization of siK1 in Y-1 cells. (a) Diagram of SIK1 protein kinase sites; T182/LKB, S577 PKA. Short and long mRNAs differing in 
terms of their 3′UTR. (B) Stimulation of SIK1 p-RNA and long mRNA (4.4 kb) by Br-cAMP. Data are represented as mean ± SEM, *P < 0.05, **P < 0.01, and 
***P < 0.001. (c) Br-cAMP (1 mM) affects the relocation of SIK1–GFP (initially nuclear) and CRTC2–GFP (initially cytoplasmic) (38). (D) Induction by the SIK1 inhibitor 
staurosporine; concentration (a), time-dependence (b), stimulation of RNA and sp-RNA at the gene loci after 60 min (c), and synergy lowering the E50 for each (d). 
(e) Br-cAMP and staurosporine induce SIK1 to a similar extent, suggesting that SIK1 exhibits feedback control.
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state within 15 min, while the 4.4-kb mRNA form that contains 
the extended 3′UTR exhibits a delay of 15  min but reaches a 
steady state after 60 min (Figure 5B). The q-PCR primers for the 
translated sequence, which quantify both mRNA forms, indicate 
that mRNA transcription responses follow the same time course 
(not shown). This 4.4-kb form, like the 3.5-kb StAR mRNA 
form, contains AU-rich elements. The SIK2 form with high 
basal expression responds minimally to Br-cAMP [Ref. (38, 49), 
p.  502]. After the inhibition of SIK2 when PKA is activated, 
CRTC2 is dephosphorylated by cytoplasmic phosphatases and 
FigUre 6 | inhibition of basal and induced expression of star by PKa-resistant siK1–s577a–gFP. (a) Nuclear location of SIK1–S577A–GFP with and 
without Br-cAMP. (B) Suppression of Br-cAMP induction (180 min) of StAR RNA at the loci or in the cytoplasm in cells that transfected with SIK1–S577A–GFP 
versus GFP. (c) Quantitative expression in transfected Y-1 cells versus neighboring untransfected cells (a, image #1 and image #2). Associated mRNA intensity in 20 
transfected cells versus 6 adjacent untransfected cells (b).
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then migrates into the nucleus (38). This relocation is stimulated 
by ACTH within the same time frame in  vivo (49). The two 
proteins complete their exchange within 15 min (Figure 5C). As 
noted earlier, some StAR loci require between 15 and 60  min 
for initiation. We found no evidence for significant asynchrony 
in CRTC2 or SIK1 transfer, indicating that the availability of 
CRTC2 and SIK1 is not a cause of asynchrony.
Staurosporine, although a general kinase inhibitor, potently 
inhibits SIK forms and induces StAR by 10-fold within 6  h 
(EC50 = 15 nM). Br-cAMP and staurosporine demonstrate effec-
tive synergy, lowering the EC50 for each (Figure 5D). Br-cAMP 
and staurosporine induce SIK1 to a similar extent, suggesting that 
SIK1 exhibits feedback control (Figure  5E). This inhibition of 
the SIK forms does not affect CREB phosphorylation. The slower 
staurosporine induction of StAR transcription compared to 
Br-cAMP should reflect additional PKA contributions, including 
CREB S133 phosphorylation.
siK1 completely Blocks star 
Transcription in Y-1 cells When PKa 
sites are Blocked by Mutations
Mutation at SIK1–S577 prevents the inhibition of SIK1 and 
also induces the complete relocation of SIK1 to the nuclear 
speckles and prevents PKA-mediated export to the cytoplasm 
(Figure 6A). We have previously shown that nuclear SIK–S577A 
does not slow the initial transfer of CRTC2–GFP to the nucleus 
but eventually limits the extent of transfer. Surprisingly, CRTC2 
FigUre 7 | selective targeting of extended star 3′UTr by transfected Tis11b/Znf36l1. (a) The structure of TIS11b/Znf36li with RNA binding Zn-finger 
domains and kinase sites. (B) Other genes exhibiting RNA target sites (TATTTATT) (51). (c) Tis11b targeted sequences are conserved in mouse and human StAR 
3′UTRs, specifically the terminal cleavage/polyadenylation site. (D) The impact of TIS11b on StAR mRNA and protein expression according to terms of the 3′UTR 
length: CMV–StAR vectors; StAR protein expression (immunoblot) and mRNA (q-PCR relative to actin) with and without Tis11b transfection (34).
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and SIK1–S577A co-localize in these nuclear speckles before 
CRTC2 is eventually phosphorylated by SIK1 and reverts to its 
cytoplasmic localization (38).
We show that the stimulation of Y-1 cells by Br-cAMP for 
180 min is completely prevented in cells that express SIK1–S577–
GFP, but not the control GFP vector (Figure 6B). StAR expres-
sion was undetectable in Y-1 cells expressing SIK1–S577A–GFP, 
but expression was normal in cells lacking the inhibitory vector 
or expressing the GFP control vector. We have quantitated the 
impact on acute expression and expression after 180  min of 
stimulation (Figure 6C).
star is selectively Targeted by Znf36l1/
Tis11b in the 3′UTr of the 3.5-kb mrna
The Zn-finger protein Znf36l1/Tis11b binds as a dimer to the 
extended 3′UTR of the 3.5-kb form of StAR through a TATTTATT 
sequence that forms a homodimer with Tis11b (Figure  7A). 
Based on this element, TIS11b targets a variety of regulatory 
proteins, including VEGF (50) (Figure 7B). This target sequence 
is conserved in the extended region of the StAR 3′UTR at equiva-
lent positions surrounding the polyadenylation site for both 
mice and humans (Figure 7C). CMV–StAR expression vectors 
differing only in their 3′UTR sequence were co-expressed with 
a TIS11b expression vector in MA-10 cells. StAR protein levels 
are most extensively decreased with the full 3′UTR sequence. 
Similar results were obtained with Y-1 cells. Co-expression of 
TIS11b specifically decreases expression of the extended 3′UTR 
that contains the TIS11b recognition element. This loss of the 
StAR protein is matched by the loss of StAR mRNA (Figure 7D).
star 3.5-kb mrna is suppressed by the 
expression of Tis11b in Y-1 and Ma-10 
cells. Deletion of Tis11b via long-term 
shrna expression
Tis11b is highly induced by Br-cAMP in MA-10 and Y-1 cells 
(Figure 8A). We tested the effects of TIS11b on StAR expression 
in MA-10 and Y-1 cells via the transient introduction of siRNA 
and shRNA and the generation of cell lines expressing a CMV-
promoted shRNA vector. Tis11b levels were reduced by the 
transfection of siRNA, 24  h prior to the addition of Br-cAMP 
(Figure 8B). The near complete suppression of TIS11b selectively 
increases StAR 3.5-kb mRNA levels by approximately 50% with-
out altering 1.6-kb mRNA levels (Figure 8C).
Tis11b was equivalently suppressed in Y-1 and MA-10 cells 
following the permanent expression of shRNA (versus scrambled 
shRNA) targeting the Tis11b sequence. This process differs from 
direct siRNA in that it requires significant cell amplification 
following the selection process. Passage number affects the PKA 
response characteristics. TIS11b suppression equally affected 
both the 3.5- and 1.6-kb forms at all doses of Br-cAMP in both 
Y-1 and MA-10 cells (Figures 8D,E). The effects of Tis11b sup-
pression correspond to a 5- to 10-fold increase in the EC50 for 
Br-cAMP in each line (Figures 8F,G).
nuclear versus cytoplasmic Distribution 
of Tis11b
Separation of the nuclei and cytoplasm in each cell line 
revealed that appreciable amounts of TIS11b were present 
FigUre 8 | suppressive effects of Tis11b in both Y-1 and Ma-10 cells. (a) Induction of TIS11b in Y-1 and MA-10 cells by 1 mM Br-cAMP, measured by 
q-PCR (34). (B) Schematic for the suppression of TIS11b using siRNA and shRNA in the indicated cell lines. (c) Time course for the selective stimulation of 3.5-kb 
StAR mRNA following the suppression of Tis11b (34). (D,e) Effects of Tis11b (shRNA) suppression on the dose–response stimulation of StAR mRNA levels. (F,g) 
Effects of Tis11b (cell line) suppression on the dose–response stimulation of Tis11b mRNA and StAR protein levels.
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in both fractions and that expression in both the nuclear 
and cytoplasmic fractions was increased by the application 
of Br-cAMP (Figure  9A). Examination of MA-10 cells by 
immunohistochemistry showed that TIS11b was predomi-
nantly present in nuclear speckles under basal conditions 
but then increased in the cytoplasm following stimulation by 
Br-cAMP with a half-life of approximately 60  min and peak 
cytoplasmic levels after 3–6 h. We also created a TIS11b–GFP 
fusion protein. Unlike native Tis11b, the fusion protein does 
not exhibit net transfer into the nucleus, even under basal 
conditions (not shown) (Figure 9B). Analysis of StAR sp-RNA 
in the nuclei and cytoplasm of cells expressing Tis11b–GFP 
indicated suppression at both the StAR loci and in the cyto-
plasm. Expression is maintained in cells expressing the GFP 
control (Figure  9C). Figure  9D illustrates the quantitation 
of mRNA in cells that individually express either or neither 
of the GFP vectors. The efficacy of Tis11b–GFP is evident. 
Finally, we show the modulation of StAR control of cholesterol 
availability via the N-terminal StAR regulatory domain, SIK1, 
and TIS11b (Figure 10).
FigUre 9 | nuclear/cytoplasmic distribution of Tis11b and activity. (a) TIS11b protein expression in the nuclei and cytoplasm of Y-1 and MA-10 cells under 
basal conditions and after stimulation (6 h/400 μM Br-cAMP). (B) Effects of stimulation time on TIS11b immunohistochemistry in MA-10 cells. (c) Stimulation of 
StAR sp-RNA/mRNA in MA-10 cells transfected with either mock CMV–GFP or CMV–Tis11b–GFP. (D) Quantitation of StAR sp-RNA/mRNA in MA-10 cells 
transfected with either mock CMV–GFP or CMV–Tis11b–GFP.
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DiscUssiOn
Previous work to elucidate the mechanism of mitochondrial 
cholesterol transfer has largely focused on the COS-1 model, in 
which StAR CBD is transfected with a functioning mitochondrial 
Cyp11a1 system (11, 52). In this model, the StAR CBD is suf-
ficient to obtain maximum cholesterol transfer, including when 
this domain anchored to the OMM. NT sequences that result in 
rapid CBD import attenuate activity, consistent with primary 
CBD activity on the OMM and low activity derived from transit 
to the IMM. However, these definitive findings raise questions 
concerning the much more potent activity observed in adrenal 
cells. In COS-1 cells, p37 StAR import and processing are similar 
to Y-1 cells (Figure  1B) but are far slower. Therefore, p37 is 
resident for longer periods of time at the OMM, shifting greater 
weight onto the OMM steps. Even in MA-10 cells, CYP11a1 levels 
are modest compared to primary adrenal cells, thus demanding 
less of the StAR transfer process. In Y-1 cells, more rapid StAR 
import delivers results in much more rapid cholesterol transfer 
with very low levels of StAR expression, including a notably 
lower proportion of OMM p37. This paper addresses the role 
of the NTD in increasing the potency of StAR and decreasing 
the inadvertent side effects of cytoplasmic StAR (53). The rapid 
removal of StAR and glucocorticoids is a component of this NTP 
activity, which is an important feature of ACTH physiology (54). 
Here, we provide an update regarding two acute cAMP-mediated 
responses in adrenal cells that antagonize the StAR mechanism.
Under physiological conditions, ACTH stimulates cholesterol 
transfer activity in adrenal cells, not only at low StAR mRNA lev-
els but also through a coordinated translation/phosphorylation 
mechanism (47). CHX inhibition results in cholesterol reaching 
the OMM, but with a distribution that provides minimal access 
to IMM Cyp11a1 (Figure 2A). This initial dependence on StAR 
CBD activity in the OMM suggests that a first step involves 
the redistribution of cholesterol to sites where transfer occurs 
to the IMM, albeit at a suboptimal rate for adrenal cells. Inter-
mitochondrial membrane and ER membrane fusion processes 
appear to be important for this process (31, 52) as well as 
proteins, such as TSPO, the sigma receptor, and various VDAC 
forms (28). A relationship with the IMM Ca-sensitive perme-
ability complex, which is regulated by TSPO/VDAC1, appears 
likely (27). Membrane cross-linking experiments have identified 
various intermembrane complexes (28), although typically under 
conditions where mitochondrial integrity has not been a point 
of focus. Here, we note the importance of this integrity because 
contacts and cholesterol transfer readily occur even when 
perturbations result in the retention of Krebs cycle activity. We 
have previously suggested that low levels of succinate depend on 
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mitochondrial integrity and ATP generation to support NADPH 
generation by NNT (8).
The deletion of 47 amino acids from the StAR NTD largely 
restores corticosterone synthesis to StAR-ko mice, but only with a 
compensating rise in cytoplasmic cholesterol. This increase alone 
should enhance mitochondrial uptake. In contrast, N-47 StAR is 
completely ineffective in Leydig cells where no such compensa-
tion occurs (15). The presence of cytoplasmic StAR that exerts 
FigUre 10 | Modulation of star control of cholesterol availability via the n-terminal star regulatory domain, siK1, and Tis11b. (a) Modulation of the 
cholesterol transfer activity of the C-terminal StAR domain by the N-terminal regulatory domain. Three functional compartments are distinguishable: green: StAR 
transfer from OMM cholesterol-binding activity and transfer of pp37 from the OMM to the IMM, where proteolytic processing occurs with possible supplemental 
activity in adrenal cells. Brown: cholesterol transfer at sites of membrane contact, possibly directed by mPTP modulation. Blue: factors modulating the partnership 
between StAR and cholesterol, including VDACs, TSPO, GTPases (OPA1, MFN2), and the activation effects of membrane fusion (ER, inter-into). (B) (a) schematic 
detailing the activities of SIK1 and CRTC2 in mediating the effects of cAMP and PKA on StAR mRNA expression in comparison to Tis11b and (b) modulation of StAR 
mRNA availability to the mitochondria by SIK1/CRTC2 (transcription and splicing) and Znf36l1/Tis11b (regulation of 3.5-kb StAR mRNA location/3′UTR processing).
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effective cholesterol transfer activity (55) redirects cholesterol 
to other sites and activities (53). The C-terminal domain (CTD) 
alone works with sufficient ACTH to overstimulate SR-B1/HSL to 
activate homeostasis directed by the SREBP and LXR forms (56).
The HR-FISH approach presented here shows individual 
StAR 3.5-kb mRNA molecules paired with single mitochondria 
(Figure  4I). StAR-mediated cholesterol transfer into adrenal 
mitochondria is a co-translational process as evidenced by the 
rapid inhibition induced by CHX. Close access of StAR mRNA to 
the mitochondria is necessary. StAR mRNA 5′-3′ dual hybridiza-
tion, size analyses, and counts per cell in terms of q-PCR copy 
numbers indicate that nearly all StAR mRNA was imaged in the 
3.5-kb form. NTD, targeting the import process, determines the 
key spatiotemporal aspects of this process. Rigorous MS analyses 
of the intermediate StAR forms revealed two conserved cleavage 
sites. Metalloprotease cleavage enzymes (MMPs) on the inside 
of the IMM generate intermembrane StAR with either BAC or 
rodent sequences. We propose that the first cleavage (A) is an 
activation step (p30/p32 likely refers to same cleavage site), while 
the second cleavage inactivates and perhaps moves the StAR core 
to LON-directed clearance sites in the matrix (53). Site A cleavage 
exposes a hydrophobic sequence in an intermediate form that 
has been recognized as being at least dually modified in 2D gels 
(1, 32). Interaction of the p30/p32 forms with VDAC2 has been 
linked to the cholesterol transfer process (14). Potent inhibition 
of this MMP cleavage in Y-1 cells by o-phenanthroline selectively 
intervenes in this process without affecting mitochondrial 
Cyp11a1 activity (1).
High-resolution fluorescence in  situ hybridization analyses 
of StAR expression at the gene loci established that slow splic-
ing of StAR p-RNA attenuates mRNA during acute stimulation 
and ultradian oscillations. Prolonged effects of stress or diurnal 
changes are necessary to increase StAR mRNA.
cAMP also rapidly induces SIK1, which decreases the tran-
scription of StAR. The ready entry of SIK1 into the nucleus and 
the susceptibility of CRTC2 to direct inhibition there through 
S-171 phosphorylation represent a rapid mechanism to minimize 
StAR p-RNA accumulation (41, 57). SIK1 induction through a 
4.4-kb labile mRNA that is induced by CREB/CRTC2 activation 
also introduces rapid feedback inhibition. SIK1 becomes active 
as cAMP and PKA activity decline, thus releasing the inhibitory 
dephosph-S577 form. SIK inhibition alone is nearly as effective as 
cAMP in producing both transcription and splicing at the StAR 
loci (Figure 5D). We expect that the high levels of SIK1 during 
the rapid cAMP decline after the application of pulsatile stimuli 
will contribute to the non-genomic decline of StAR p-RNA (54).
TIS11b exclusively targets the terminal segment of the 3.5-
kb mRNA through the formation of homodimers at conserved 
AU-rich sites in the extended 3′UTR. This control mechanism, 
likely targeting the mitochondria (44), provide an explanation 
for the near-exclusive initial formation of the 3.5-kb mRNA, 
although this form is less stable, and the 1.6-kb form is an 
equivalent source of protein (46). Tis11b may target nuclear 
StAR p-RNA and 3.5-kb mRNA prior to conversion to the 1.6-
kb mRNA form. Interestingly, Tis11b mRNA is also expressed 
with a long 3′UTR that contains the homodimer recognition 
element, thus allowing self-regulation. Tis11b, the SIK forms, 
and CRTC2 can function coordinately through the shared 
and competitive binding of their phosphorylated forms to 
cytoplasmic 14–3–3.
highlights for star regulation in adrenal 
cells
Adrenocorticotropic hormone stimulation of cholesterol 
metabolism requires continuous translation and phosphoryla-
tion of p37 StAR. The CBD generates substantial activity through 
the redistribution of cholesterol at the OMM aided by other 
OMM proteins, including TSPO and VDAC1. Peak glucocor-
ticoid formation is achieved with low basal levels of the 3.5-kb 
mRNA form, which individually pairs with single mitochondria. 
Cholesterol transfer may be enhanced by conserved site A NTD 
cleavage by IMM metalloproteases and terminated by site B 
cleavage. StAR 3.5-kb mRNA formation is slowed by a pause in 
elongation, slow splicing, and the intervention of TIS11b through 
sites at the end of the 3′UTR. Dephosphorylated CRTC assumes 
control of transcription and splicing at StAR gene loci, where 
p-RNA and sp-RNA have been spatially separated by HR-FISH. 
The inhibition of SIK forms alone replicates the PKA activation 
of StAR expression in adrenal cells. cAMP-mediated induction of 
SIK1 by ACTH attenuates StAR through migration into nuclear 
sites shared with CRTC2, once ACTH levels and cAMP decline 
during physiological pulses.
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